ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $285 | -27.5% | 42,435 | -4.7% | 0.00% | 0.0% |
| Q1 2023 | $393 | -82.4% | 44,517 | -84.8% | 0.00% | -83.3% |
| Q4 2022 | $2,236 | -99.9% | 292,743 | +1.5% | 0.01% | 0.0% |
| Q3 2022 | $2,054,000 | -7.6% | 288,547 | +5.0% | 0.01% | 0.0% |
| Q2 2022 | $2,222,000 | -45.4% | 274,760 | -6.2% | 0.01% | -25.0% |
| Q1 2022 | $4,067,000 | -75.3% | 292,956 | -50.2% | 0.01% | -75.0% |
| Q4 2021 | $16,493,000 | -13.9% | 587,770 | +4.4% | 0.03% | -17.9% |
| Q3 2021 | $19,145,000 | -14.7% | 563,262 | +2.6% | 0.04% | -15.2% |
| Q2 2021 | $22,439,000 | +27.2% | 549,176 | +25.3% | 0.05% | +17.9% |
| Q1 2021 | $17,638,000 | +3629.0% | 438,125 | +5371.1% | 0.04% | +3800.0% |
| Q4 2020 | $473,000 | – | 8,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |